Literature DB >> 28712936

Prognostic and diagnostic potential of suPAR levels in pleural effusion.

Lucie-Marie Matzkies1, Reinhard Bernd Raggam2, Holger Flick3, Jasmin Rabensteiner4, Gebhard Feierl5, Martin Hoenigl6, Juergen Prattes7.   

Abstract

Entities:  

Keywords:  Pleural effusion; Prognosis; Urokinase activator receptor

Mesh：

Substances：

Year:  2017        PMID： 28712936     DOI： 10.1016/j.jinf.2017.07.002

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

1.  Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.

Authors:  Qiongzhen Luo; Pu Ning; Yali Zheng; Ying Shang; Bing Zhou; Zhancheng Gao
Journal:  Crit Care       Date:  2018-01-24       Impact factor: 9.097

2.  Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.

Authors:  David T Arnold; Fergus W Hamilton; Karen T Elvers; Stuart W Frankland; Natalie Zahan-Evans; Sonia Patole; Andrew Medford; Rahul Bhatnagar; Nicholas A Maskell
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

3.  suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection.

Authors:  Steven Idell; Y C Gary Lee
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.